About

Provided by Mintz

Since the birth of the life sciences industry in the 1970s, Mintz Levin has provided our clients with the experience, resources, and insights to help them meet their goals. Today, we advise life science companies of every size, from start-ups looking for their first funding to public companies with products on the market, as well as venture capital firms, investment banks, research and academic institutions, and others engaged in the life sciences ecosystem.


Corporate

  • IPOs, follow-on offerings, and PIPE transactions​
  • Reverse mergers, Form 10s, and APOs
  • Securities regulatory compliance and corporate governance advice
  • Mergers and acquisitions
  • Strategic collaborations and licensing
  • Angel and venture capital financing
  • Equity compensation


Intellectual Property

  • Patent prosecution and strategy
  • Patent infringement litigation
  • Hatch-Waxman Paragraph IV litigation
  • Alternative dispute resolution
  • Trademark strategy and registration


Compliance & Regulation

  • FDA regulatory counseling
  • Clinical trials
  • Compliance planning
  • Health care fraud and abuse
  • Reimbursement

Clients

Provided by Mintz

Biogen Inc.

Boston Scientific Corporation

Igenica, Inc.

Intarcia Therapeutics, Inc.

NephroGenex, Inc.

Neurimmune Therapeutics AG

NeuroMetrix, Inc.

OvaScience, Inc.

QIAGEN N.V.

Regeneron

Roche Diagnostics

Rosetta Genomics Ltd.

Takeda Pharmaceuticals